About GramEye
GramEye is a company based in Osaka (Japan) founded in 2020. GramEye has raised $9.67 million across 4 funding rounds from investors including Samurai Incubate, Études and SMBC Venture Capital. GramEye operates in a competitive market with competitors including Smart4Diagnostics, Avicena Systems, Biophos, Milab Online and BeaconLBS, among others.
- Headquarter Osaka, Japan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.67 M (USD)
in 4 rounds
-
Latest Funding Round
$3.64 M (USD), Series B
Nov 24, 2025
-
Investors
Samurai Incubate
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GramEye
GramEye has successfully raised a total of $9.67M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $3.64 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GramEye
GramEye has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Samurai Incubate, Études and SMBC Venture Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Études is recognized for innovative architectural solutions and services.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Entrepreneurs are supported through funding and guidance by NES.
|
Locked | Locked | Locked |
Investor details for GramEye
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GramEye
Investment portfolio details for GramEye
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GramEye
Detailed financials for GramEye
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Grameye Comparisons
Peer comparison for GramEye
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GramEye
GramEye operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Smart4Diagnostics, Avicena Systems, Biophos, Milab Online and BeaconLBS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Blood sample measurement devices are manufactured for real-time diagnostics.
|
|
| Locked | Locked | Locked |
Developer of biosecurity platform and hardware for pathogen testing
|
|
| Locked | Locked | Locked |
Offers tools and solutions for automating fertility analysis processes.
|
|
| Locked | Locked | Locked |
Online platform for requesting and viewing veterinary laboratory test results.
|
|
| Locked | Locked | Locked |
Delivers comprehensive point-of-care laboratory solutions for healthcare professionals.
|
Detailed competitors of GramEye
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Grameye
Complete news archive for GramEye
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GramEye
GramEye was founded in 2020 and raised its 1st funding round 3 years after it was founded.
GramEye is headquartered in Osaka, Japan. It is registered at Osaka, Osaka Prefecture, Japan.
Yu Hiraoka is the current CEO of GramEye.
GramEye is a funded company, having raised a total of $9.67M across 4 funding rounds to date.
GramEye was founded in 2020 in Osaka, Japan, focusing on AI and robotics within the healthcare sector. Solutions are provided to assist outpatient clinics in estimating bacterial species from samples. Disease detection is enabled through this technology, helping to avoid prescriptions of unnecessary medications that contribute to drug-resistant bacteria. Operations center on pathological testing advancements for clinical use.
GramEye's top competitors include Smart4Diagnostics, Avicena Systems and Biophos.
GramEye has 8 investors. Key investors include Samurai Incubate, Études, SMBC Venture Capital, NES Venture Capital, and DEEPCORE.